Global Endometrial Cancer Therapeutics Market Projections, SWOT Analysis, Risk Analysis, Trends and Forecast by 2023 – Market Research Report 2017 has published new research report on "Global Endometrial Cancer Therapeutics Market Research Report and Forecast to 2017-2023" to its database.

Dallas, United States - July 17, 2017 /MarketersMedia/ —

Endometrial Carcinoma is a common form of cancer of the female reproductive system that initiates in the lining of the uterus. According to the American Cancer Society, endometrial cancer is also the most common cancer of the female reproductive organs in the US. About 60,050 new cases of cancer of uterus were estimated to be diagnosed during 2016, and about 10,470 women died from cancers of the uterine body during the same year.Early detection of endometrial cancer helps in the selection of proper treatment options. Endometrial Cancer can be treated by one or combination of therapies, such as chemotherapy, radiation therapy, hormone therapy, and surgery. Most of the physicians generally recommend combination treatments because chemotherapy alone has conventionally been deemed ineffective. Furthermore, adjuvant radiation therapy is ideal in patients who have diagnosed with Stage I or II endometrial cancer. Radiation Therapy is also recommended in patients who have undergone the surgery to avoid the relapse of endometrial cancer.

Browse the report:

According to the RNCOS report entitled “Global Endometrial Cancer Therapeutics Market By Therapy (Chemotherapy, Hormone Therapy, Radiation Therapy, Surgery), By Enduser (Research Institutes, Hospitals & Clinics), & Pipeline Analysis, Outlook to 2023”, the Endometrial Cancer therapeutics market is poised to reach approximately US$ 27 Billion by 2023. In this report, there is in-depthmarket analysis as well as market segmentation of global endometrial cancer therapeutics. The market potential of endometrial cancer therapeutic drugsisestimated considering that these are being tested in clinical trials for endometrial cancer, besides the ones which have already been approved. The depictedendometrial cancer therapeutic drugsare expected to show their complete market potential soon in the coming years.

Furthermore, in this report we have structured the information on epidemiology of endometrial cancer in the world. The report also covers pipeline analysis of endometrial cancer therapeutic drugs at various stages of clinical development that are under research or in collaboration, and those individually being developed by companies. Moreover, our report places an emphasis on the major drivers and challenges, latest trends and developments,as well as strategic collaborations that can impact industry’s growth.

Request a sample of the report:

In the end, the report enlists some of the key players in the Endometrial Cancer Therapeutics market including business overview of each player along with their product and pipeline portfolios, recent developments, and comparative analysis of their strengths and weaknesses.Conclusively, the report will prove to be a complete and comprehensive source of knowledge and analysis for clients and potential investors or debut makers in this industry.

Major Points From The Table Of Contents:
Analyst View
Research Methodology
Endometrial Cancer - Epidemiology & Risk Factors
Endometrial Cancer Therapeutics - An Introduction
Market Dynamics
Endometrial Cancer Therapeutics Market Outlook to 2023
Market Segmentation
Endometrial Cancer Therapeutic Drugs Pipeline Analysis
Trends and Developments
Strategic Mergers & Collaborations in the Endometrial Cancer Therapeutics Industry
Competitive Assessment

Buy the report@

List of Figures:
Figure 3-1: Estimated Age-specific Incidence & Mortality Rates for Endometrial Cancer, 2016
Figure 4-1: Endometrial Cancer Therapeutic Drugs - Mechanism of Action
Figure 5-1: Global Healthcare Spending (Billion US$), 2015 & 2020
Figure 5-2: Healthcare Spending by Region (Billion US$), 2015 & 2020
Figure 6-1: Global - Endometrial Cancer Therapeutics Market (Billion US$), 2016-2023
Figure 7-1: Global - Endometrial Cancer Therapeutics Market by Therapy (%), 2016
Figure 7-2: Global - Endometrial Cancer Chemotherapy Market (Billion US$), 2016 & 2023
Figure 7-3: Global - Endometrial Cancer Hormone Therapy Market (Billion US$), 2016 & 2023
Figure 7-4: Global - Endometrial Cancer Radiation Therapy Market (Billion US$), 2016 & 2023
Figure 7-5: Global - Endometrial Cancer Surgery Market (Billion US$), 2016 & 2023
Figure 7-6: Global - Endometrial Cancer Therapeutics Market by End Users (%), 2016
Figure 7-7: Global - Endometrial Cancer Therapeutics Market by Research Institutes (Billion US$), 2016 & 2023
Figure 7-8: Global - Endometrial Cancer Therapeutics Market by Hospitals (Billion US$), 2016 & 2023

List of Tables:
Table 6-1: Potential Patients for Endometrial Cancer Therapeutics, 2015, 2020 & 2025
Table 8-1: Industrial Endometrial Cancer Therapeutic Drugs Pipeline
Table 8-2: Research Collaborations Endometrial Cancer Therapeutic Drugs Pipeline
Table 10-1: Strategic Mergers & Collaborations in Endometrial Cancer Therapeutics Industry, 2014-2016
Table 11-1: Top Companies by Endometrial Cancer Therapeutic Drugs in Pipeline (2016)
Table 11-2: Bayer AG - Endometrial Cancer Therapeutic Drugs in Pipeline
Table 11-3: Bayer AG - Key Financials (Million US$), 2014-2016
Table 11-4: F. Hoffman La Roche Ltd. - Endometrial Cancer Therapeutic Drugs in Pipeline
Table 11-5: F. Hoffman La Roche Ltd. - Key Financials (Million US$), 2014-2016

About Us:
Orbis Research ( is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Info:
Name: Hector Costello
Organization: Orbis Research
Address: 4144N Central Expressway, Suite 600, Dallas, Texas – 75204, U.S.A.
Phone: +1 (214) 884-6817

Source URL:

For more information, please visit

Source: MarketersMedia

Release ID: 217971

Latest News

Rare birds, wildflowers: 'Secret garden' opens after century

Jul 28, 2017

TRUCKEE, Calif. — Pink and yellow wildflowers burst from a lush bed of grass hidden from public view for more than a century. Towering trees and snow-capped mountains encircle the wild meadow, beckoning visitors to a largely untouched piece of California's Sierra Nevada. Conservation groups bought the land in Lower Carpenter Valley north of Lake Tahoe and are opening it for tours. It contains rare carnivorous plants and threatened birds and serves as a migration corridor for other species. Bird songs and the gurgle of a serpentine creek provide the soundtrack in the meadow less than 8 miles from noisy...

Indonesia orangutan sanctuary says villagers encroaching

Jul 28, 2017

JAKARTA, Indonesia — A conservation group says nearly a fifth of the forest in an orangutan sanctuary on the Indonesian part of Borneo has been taken over by people, threatening efforts to rehabilitate the critically endangered great apes for release into the wild. People thought to have migrated from other parts of Indonesia have occupied part of the sanctuary, cut down trees and planted crops including palm oil, Borneo Orangutan Survival Foundation spokesman Nico Hermanu said Thursday. The human activities are near a "forest school" where more than 20 orangutans live semi-independently and learn how to find food, build nests...

Warming to worsen dead zones, algae blooms choking US waters

Jul 28, 2017

WASHINGTON — Projected increases in rain from global warming could further choke U.S. waterways with fertilizer runoff that trigger dead zones and massive algae blooms, a new study said. If greenhouse gas emissions keep rising, more and heavier rain will increase nitrogen flowing into lakes, rivers and bays by about 19 percent by the end of the century, according to a study in Thursday's journal Science . While that may not sound like much, many coastal areas are already heavily loaded with nitrogen. Researchers calculated that an extra 860,000 tons of nitrogen yearly will wash into American waterways by century's...

Prosecutor: Martin Shkreli repeatedly lied to investors

Jul 28, 2017

NEW YORK — A prosecutor at the securities fraud trial of Martin Shkreli says the former pharmaceutical CEO scammed investors in a pair of failed hedge funds. Prosecutor Alixandra Smith told a jury in closing arguments on Thursday that Shkreli repeatedly lied to investors about how much money was in one of the funds as it was going under. She said he assured investors that he was managing $40 million at a time when there as only a few hundred dollars in his firm's brokerage account. In a recent Facebook post, the 34-year-old defendant calls the case "bogus." Before his...

Businesses, cities cashing in on total solar eclipse crowds

Jul 28, 2017

BARTLETT, Tenn. — Millions of eyes will be fixed on the sky when a total solar eclipse crosses the U.S. in August. It's likely many of them will be safely behind the special glasses churned out by a Tennessee company. American Paper Optics ramped up production for this year's eclipse and expects to make 50 million paper and plastic eclipse glasses. The company in suburban Memphis is one of many businesses — hotels, campgrounds and stores — taking advantage of the total solar eclipse. The total eclipse will move across the country from Oregon to South Carolina on Aug. 21....


Recent Discovery will take you to the captivating developments in science, technology, and the universe around us. We deliver to you the latest news, theories, and developments in the world of science.

Contact us:

Trending News

ScienceAgricultural ScienceArchaeologyAstronomy Press